Big Pharma Loses Again! But Will Trump's Deals Lower Your Drug Prices? w/ Merith Basey, Patients for Affordable Drugs

Big Pharma just lost again in court - but will your drug prices actually go down? On this Care Talk, Merith Basey from Patients for Affordable Drugs joins host Laura Packard for an update on the Medicare drug price negotiation lawsuits, Trump's Most Favored Nation deals with drug manufacturers, and what it all means for patients. A federal appeals court just rejected PhRMA's challenge to Medicare negotiation, the latest in a string of losses for industry lawsuits. At the same time, the Trump administration says it has struck Most Favored Nation (MFN) pricing deals with 16-17 major manufacturers, starting with Pfizer, plus 9 new companies announced in late August, alongside the launch of TrumpRx.gov. Critics call the deals a farce with secret terms and no real enforcement. Merith breaks down: which lawsuits are still alive, what's actually in the MFN deals, and whether Medicare negotiation or MFN will lower what you pay at the pharmacy counter. Also Louise Norris of healthinsurance.org and Rachel Madley of Center for Health & Democracy answer your health insurance questions on the Affordable Care Act, Medicare, Medicaid, private insurance and more. Topics include what to know for this Medicare open enrollment season, the Trump administration's proposed $500 Obamacare rebates, why can a drug be so much more expensive when not covered by insurance, and does preventative care really mean free of charge. LINKS & RESOURCES: • Free or Low Cost Health Care Resources: https://healthcarevoices.org/caretalk SUBSCRIBE to Care Talk for weekly health care policy breakdowns that put patients first. #Medicare #DrugPrices #BigPharma #healthcare — Laura Packard is a stage 4 cancer survivor, health care advocate, and host of Care Talk. Founder of Health Care Voices and Voices of Health Care Action.